| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Sherwin Stephen A serves as a Director at BIIB and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 17 sells.
Historically, Sherwin Stephen A's trades have earned a below-average insider score of 40/100 across 5 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -14.9%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | NBIX Neurocrine Biosciences, Inc. | Director | Sale+OE10b5-1 | 25,000 | $165.32 | $4,132,968.88 | -61.2% | -3.4% | - | |
| Mar 7, 2025 | BIIB Biogen Inc. | Director | Sell10b5-1 | 8,760 | $150.02 | $1,314,141.91 | -43.6% | -13.3% | +22.9% | |
| Feb 13, 2025 | NBIX Neurocrine Biosciences Inc | Director | Sell10b5-1 | 13,831 | $116.69 | $1,613,922.79 | -56.4% | +1.6% | +6.2% | |
| May 29, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE10b5-1 | 40,000 | $133.46 | $5,338,564.50 | -60.1% | +13.3% | -8.1% | |
| Jan 3, 2023 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 30,000 | $118.86 | $3,565,728.00 | -54.5% | -16.0% | +10.5% | |
| Jan 24, 2022 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 15,000 | $74.43 | $1,116,378.00 | -37.4% | +23.6% | +43.2% | |
| Apr 28, 2020 | NBIX Neurocrine Biosciences Inc | Director | Sell | 17,687 | $99.39 | $1,757,965.76 | -37.2% | - | - | |
| Mar 11, 2020 | BIIB Biogen Inc. | Director | Sale+OE | 2,434 | $295.22 | $718,573.56 | -13.6% | - | - | |
| Jun 11, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sell | 10,000 | $98.44 | $984,420.00 | -17.4% | - | - | |
| Mar 10, 2015 | BIIB Biogen Inc. | Director | Sale+OE | 6,000 | $409.67 | $2,458,020.00 | -59.1% | - | - |